sevoflurano 250 ml liquido inhalable
baxter healthcare corporation [pr] puerto rico - sevoflurano (fluoromethyl 2.2.2-trifluoro-1 (trifluoromethyl) ethyl eter) 250ml - soluciÓn para inhalaciÓn - sevoflurano (fluoromethyl 2.2.2-trifluoro-1 (trifluoromethyl) ethyl eter) 250ml
suprane ® liquido anestesico para inhalacion
baxter healthcare corporation [pr] puerto rico - desflurano 100% - lÍquido - cada frasco contiene desflurano usp 100%
dexmedetomidina 4 mcg /ml en cloruro de sodio al 0.9%
baxter healthcare corporation estados unidos - cada ml contiene: dexmedetomidina clorhidrato 4,72 mcg equivalente a dexmedetomidina 4 mcg - solucion inyectable - cada ml contiene: dexmedetomidina clorhidrato 4,72 mcg equivalente a dexmedetomidina 4 mcg
isoflurano baxter 100 % solución para inhalación
baxter healthcare corporation - solución para inhalación - 100%
sevoflurano 100% baxter solución para inhalación
baxter healthcare corporation - solución para inhalación - 100%
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agentes antineoplásicos - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
sugammadex baxter 100 mg/ml solucion inyectable efg
baxter holding b.v. - sugammadex - soluciÓn inyectable - 100 mg/ml inyectable 5 ml - sugammadex 100 mg - sugammadex
glucosa 3,33% y cloruro sódico 0,3% baxter solución para perfusión.
baxter s.l. - glucosa monohidrato; sodio cloruro - soluciÓn para perfusiÓn - 3,3% + 0,3% - glucosa monohidrato 33 mg; sodio cloruro 3 mg - suero glucosalino
suero fisiológico baxter 9 mg/ml, solución para perfusión
baxter s.l. - sodio cloruro - soluciÓn para perfusiÓn - 0,9% - sodio cloruro 9 mg - sodio cloruro, solución parenteral
glucosa baxter 10% solución para perfusión
baxter s.l. - glucosa monohidrato - soluciÓn para perfusiÓn - 10% - glucosa monohidrato 100 mg - carbohidratos